Evidence map›Paper›PMID 30408165›Full record

ArticleThe Journal of comparative neurology2019

Distribution of endogenous normal tau in the mouse brain.

Atsuko Kubo, Hiroaki Misonou, Makoto Matsuyama, Akane Nomori, Satoko Wada-Kakuda, Akihiko Takashima, Mitsuhiro Kawata, Shigeo Murayama, Yasuo Ihara, Tomohiro Miyasaka

Abstract read
In one paragraph

Article in The Journal of comparative neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Longitudinal CSF and Serum Biomarker Dynamics in Tofersen-TreatedInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Atsuko KuboDepartment of Neuropathology, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.
Hiroaki MisonouLaboratory of Ion Channel Pathophysiology, Graduate School of Brain Science, Doshisha University, Kyoto, Japan.
Makoto MatsuyamaDivision of Molecular Genetics, Shigei Medical Research Institute, Okayama, Japan.
Akane NomoriDivision of Molecular Genetics, Shigei Medical Research Institute, Okayama, Japan.
Satoko Wada-KakudaDepartment of Neuropathology, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.
Akihiko TakashimaLaboratory for Alzheimer's Disease, Department of Life Science, Faculty of Science, Gakushuin University, 1-5-1 Mejiro, Toshima-ku, 171-8588, Tokyo, Japan.
Mitsuhiro KawataDepartment of Physical Therapy, School of Health Sciences, Bukkyo University, Nakagyo-ku, Kyoto, 604-8418, Japan.
Shigeo MurayamaNeuropathology, The Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan.
Yasuo IharaDepartment of Neuropathology, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.
Tomohiro MiyasakaDepartment of Neuropathology, Faculty of Life and Medical Sciences, Doshisha University, Kyoto, Japan.ORCID 0000-0003-4867-7910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tau is a microtubule-associated protein (MAP) that is localized to the axon. In Alzheimer's disease (AD), the distribution of tau undergoes a remarkable alteration, leading to the formation of tau inclusions in the somatodendritic compartment. While the abnormal aggregated tau has been extensively studied in human patient tissues and animal models of AD, how normal tau localizes to the axon, which would be the foundation to understand how the mis-localization occurs, has not been well studied due to the poor detectability of normal unaggregated tau in vivo. Therefore, we developed immunohistochemical techniques that can detect normal mouse and human tau in brain tissues with high sensitivity. Using these techniques, we demonstrate the global distribution of tau in the mouse brain and confirmed that normal tau is exclusively localized to the axonal compartment in vivo. Interestingly, tau antibodies strongly labeled nonmyelinated axons such as hippocampal mossy fibers, while white matters generally exhibited low levels of immunoreactivity. Furthermore, mouse tau is highly expressed not only in neurons but also in oligodendrocytes. With super resolution imaging using the stimulated-depletion microscopy, axonal tau appeared punctate rather than fibrous, indicating that tau decorates microtubules sparsely. Co-labeling with presynaptic and postsynaptic markers revealed that normal tau is not localized to synapses but sparsely distributes in the axon. Taken together, this study reports novel antibodies to investigate the localization and mis-localization of tau in vivo and novel findings of normal tau localization in the mouse brain.

Indexed as

AnimalsAntibodiesBrainFemaleHumansImmunohistochemistryMaleMice, TransgenicMicrotubulesNeurogliaNeuronstau ProteinsAntibodiesMAPT protein, humanMapt protein, mousetau ProteinsaxonlocalizationmicrotubuleRRID:AB_10711040RRID:AB_1281142RRID:AB_2028812RRID:AB_2157541RRID:AB_223648RRID:AB_2314906RRID:AB_305869RRID:AB_397999RRID:AB_441973RRID:AB_477193RRID:AB_530937RRID:AB_839504RRID:AB_887878RRID:AB_922392RRID:AB_94855RRID:AB_94944STEDtau

Identifiers

PMID30408165
PMCPMC6587864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.